Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?

INTRODUCTION: Sodium-glucose co-transporter 2 inhibitors (SGLT2is) are a unique class of drugs currently used in the management of type 2 diabetes (T2D). There are emerging data from cardiovascular outcome trials confirming renal and heart failure benefits of these drugs independent of glucose lower...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinton, William, Feher, Michael, Munro, Neil, de Lusignan, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434824/
https://www.ncbi.nlm.nih.gov/pubmed/32671574
http://dx.doi.org/10.1007/s13300-020-00878-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434824/
https://www.ncbi.nlm.nih.gov/pubmed/32671574
http://dx.doi.org/10.1007/s13300-020-00878-y

Ejemplares similares